103 related articles for article (PubMed ID: 25502430)
1. Managing symptoms and maximizing quality of life after preventive interventions for cancer risk reduction.
Chapman JS; Jacoby V; Chen LM
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):40-4. PubMed ID: 25502430
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of patients at inherited risk for gynecologic cancer.
Powell CB
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):14-22. PubMed ID: 25490378
[TBL] [Abstract][Full Text] [Related]
4. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
5. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
[TBL] [Abstract][Full Text] [Related]
6. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
Finch A; Metcalfe KA; Chiang J; Elit L; McLaughlin J; Springate C; Esplen MJ; Demsky R; Murphy J; Rosen B; Narod SA
Psychooncology; 2013 Jan; 22(1):212-9. PubMed ID: 21913283
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
Finch A; Narod SA
Maturitas; 2011 Nov; 70(3):261-5. PubMed ID: 21893388
[TBL] [Abstract][Full Text] [Related]
9. Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
Vermeulen RFM; Beurden MV; Korse CM; Kenter GG
Climacteric; 2017 Jun; 20(3):212-221. PubMed ID: 28509627
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
11. The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.
Moldovan R; Keating S; Clancy T
Fam Cancer; 2015 Mar; 14(1):51-60. PubMed ID: 25342222
[TBL] [Abstract][Full Text] [Related]
12. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Roukos DH; Briasoulis E
Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
[TBL] [Abstract][Full Text] [Related]
13. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
14. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic surgery in common hereditary cancer syndromes].
Noguès C; Mouret-Fourme E
Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
[TBL] [Abstract][Full Text] [Related]
17. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
Arai M; Iwase T; Takazawa Y; Takeshima N
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
[TBL] [Abstract][Full Text] [Related]
18. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
Ballinger LL
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
[TBL] [Abstract][Full Text] [Related]
19. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
[TBL] [Abstract][Full Text] [Related]
20. Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.
McCann GA; Eisenhauer EL
J Surg Oncol; 2015 Jan; 111(1):118-24. PubMed ID: 25139656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
